Concepedia

Mingfeng Lu

ML

Statistics

Publications

2

Citations

47

H-Index

2

Active since

2025

Affiliations

Bayer (Switzerland)(Current)

Mingfeng Lu is an author at Bayer (Switzerland) specializing in cardiovascular outcome trials, endpoint interpretation, and comparative safety evaluation.

Publications per year

2025–2025

2

Publications

2

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

Faı̈ez Zannad, Christopher M. O’Connor, Javed Butler et al. · The Lancet · 2025 · 32 citations · Full text

, , +17

Quercetin-primed MSC exosomes synergistically attenuate osteoarthritis progression

Mingfeng Lu, Aiju Lou, Junqing Gao et al. · Journal of Orthopaedic Surgery and Research · 2025 · 15 citations · Full text

, , +17

1–2 of 2